|
[1] Darin N, Oldfors A, Moslemi A R, et al.The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities[J]. Ann Neurol, 2001, 49(3): 377-383. [2] Thorburn D R.Mitochondrial disorders: prevalence, myths and advances[J]. J Inherit Metab Dis, 2004, 27(3): 349-362. [3] Ikeda T, Osaka H, Shimbo H, et al.Mitochondrial DNA 3243A>T mutation in a patient with MELAS syndrome[J]. Hum Genome Var, 2018, 5: 25. [4] Tetsuka S, Ogawa T, Hashimoto R, et al.Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS[J]. Metab Brain Dis, 2021, 36(8): 2181-2193. [5] Gagliardi D, Mauri E, Magri F, et al.Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature[J]. Front Neurol, 2019, 10: 38. [6] Li J, Zhang W, Cui Z, et al.Epilepsy Associated With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes[J]. Front Neurol, 2021, 12: 675816. [7] Rahman S.Mitochondrial disease in children[J]. J Intern Med, 2020, 287(6): 609-633. [8] 赵静,王训,程楠,等. 线粒体脑肌病伴乳酸血症和卒中样发作综合征的临床、EEG、影像学及肌肉病理特点分析[J]. 临床神经病学杂志,2021,34(2):121-126. [9] Li X, Wang Y, Wang Z, et al.Comparison of magnetic resonance spectroscopy (MRS) with arterial spin labeling (ASL) in the differentiation between mitochondrial encephalomyopathy, lactic Acidosis, plus stroke-like episodes (MELAS) and acute ischemic stroke (AIS)[J]. J Clin Neurosci, 2018, 55: 65-70. [10] Rodriguez M C, MacDonald J R, Mahoney D J, et al. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders[J]. Muscle Nerve, 2007, 35(2): 235-242. [11] Barcelos I, Shadiack E, Ganetzky R D, et al.Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines[J]. Curr Opin Pediatr, 2020, 32(6): 707-718.
|